Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» bb21217
bb21217
As Abecma sales take off, Bristol Myers and 2seventy scrap a follow-up CAR-T
Endpoints
Thu, 01/13/22 - 07:21 am
Bristol Myers Squibb
2seventy bio
Abecma
bb21217
CAR-T
bluebird bio to Cut Ribbon on New Gene Therapy Factory in Durham, NC; Plans to Hire
BioSpace
Fri, 03/22/19 - 10:06 pm
Bluebird Bio
gene therapy
drug manufacturing
bb2121
bb21217
LentiGlobin
Where Will bluebird bio Be in 5 Years?
Motley Fool
Thu, 01/24/19 - 11:41 am
Bluebird Bio
LentiGlobin
bb21217
CAR-T
Can Celgene and bluebird bio Survive a Two-Pronged Attack?
Motley Fool
Wed, 12/5/18 - 11:54 am
Celgene
Bluebird Bio
bb21217
ASH18: Bluebird's follow-on CAR-T finds initial success, but durability will be key test
Biopharma Dive
Sun, 12/2/18 - 10:50 pm
ASH2018
Bluebird Bio
CAR-T
bb21217
3 Cancer Stocks to Watch in December
Motley Fool
Wed, 11/7/18 - 10:06 am
Acceleron
luspatercept
Bluebird Bio
bb21217
Amgen
AMG 420